| Literature DB >> 34727649 |
Lijun Shi1, Longchao Zhang1, Ligang Wang1, Xin Liu1, Hongmei Gao1, Xinhua Hou1, Fuping Zhao1, Hua Yan1, Wentao Cai1, Lixian Wang1.
Abstract
OBJECTIVE: This study was conducted to identify the functional long non-coding RNAs (lncRNAs) for swine lactation by RNA-seq data of mammary gland.Entities:
Keywords: Colostrum; LncRNA; Mammary Gland; Pig; Weighted Gene Co-expression Network Analysis (WGCNA)
Year: 2021 PMID: 34727649 PMCID: PMC9066039 DOI: 10.5713/ab.21.0308
Source DB: PubMed Journal: Anim Biosci ISSN: 2765-0189
Figure 1(A) The process for identifying lncRNAs. Principal component analysis (PCA) analysis based on the expression of lncRNAs: (B) PC1 and PC2 could separate the samples by phenotype of stages of lactation; and (C) PC2 and PC3 could separate the samples by individuals.
Figure 2Identification of DE lncRNAs and mRNAs. (A) Volcano plot dispalys DE lncRNAs and mRNAs of day −10 vs day −14. (B) Volcano plot dispalys DE lncRNAs and mRNAs of day −6 vs day −14. (C) Volcano plot dispalys DE lncRNAs and mRNAs of day −2 vs day −14. (D) Volcano plot dispalys DE lncRNAs and mRNAs of day +1 vs day −14. The novel DE lncRNAs was marked. DE, differentially expressed.
Figure 3Venn diagram shows the number of differentially expressed (DE) lncRNAs overlapping in different swine mammary gland development stages or unique to each developmental stage. −14, at days 14 before parturition; −10, at days 10 before parturition; −6, at days 6 before parturition; −2, at days 2 before parturition; +1, at days 1 after parturition.
Figure 4Expression pattern of differentially expressed (DE) lncRNAs across five stages. The colored lines represent that the different lncRNA changes.
Figure 5WGCNA at each swine mammary gland development. (A) Hierarchical cluster tree showing co-expression modules identified by WGCNA. (B) Module-sample relationships. Each column indicates a sample, and each row represents a module. The correlation coefficient and p-value of each sample-module relationship are displayed. Red represents high correlation value, and green represents low correlation value. WGCNA, weighted gene co-expression network analysis.
GO and KEGG enrichments of 23 potentially functional lncRNAs and their 25 target genes
| LncRNA | Group | Target gene | ID | Term | p-value |
|---|---|---|---|---|---|
| XLOC_020627 | −2vs−14 |
| ssc04530 | Tight junction | 1.75E-03 |
| GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 4.03E-02 | |||
| ssc04670 | Leukocyte transendothelial migration | 1.92E-02 | |||
| ENSSSCG00000051193 | 1vs−14 |
| ssc04921 | Oxytocin signaling pathway | 6.73E-03 |
| ssc04923 | Regulation of lipolysis in adipocytes | 3.09E-02 | |||
| XLOC_025150[ | −10vs−14, −6vs−14, −2vs−14, 1vs−14 |
| GO:0030879 | mammary gland development | 1.49E-06 |
| GO:0007595 | lactation | 1.48E-03 | |||
| ENSSSCG00000042618 | −2vs−14 |
| GO:0030879 | mammary gland development | 1.49E-06 |
| GO:0061180 | mammary gland epithelium development | 2.94E-03 | |||
| GO:0060644 | mammary gland epithelial cell differentiation | 3.46E-02 | |||
| GO:0009792 | embryo development ending in birth or egg hatching | 4.80E-02 | |||
| GO:0071396 | cellular response to lipid | 2.42E-02 | |||
| GO:0008144 | drug binding | 3.27E-02 | |||
| XLOC_963181 | −2vs−14, 1vs−14 |
| GO:0009792 | embryo development ending in birth or egg hatching | 4.80E-02 |
| GO:0071396 | cellular response to lipid | 2.42E-02 | |||
| GO:0008144 | drug binding | 3.27E-02 | |||
| GO:0032526 | response to retinoic acid | 4.35E-03 | |||
| XLOC_026156 | −10vs−14, −6vs−14, −2vs−14, 1vs−14 |
| ssc04920 | Adipocytokine signaling pathway | 6.51E-03 |
| ENSSSCG00000011196[ | −2vs−14, 1vs−14 |
| ssc00512 | Mucin type O-glycan biosynthesis | 6.33E-04 |
| ENSSSCG00000036096 | −6vs−14, −2vs−14, 1vs−14 |
| ssc04530 | Tight junction | 1.75E-03 |
| ssc04670 | Leukocyte transendothelial migration | 1.92E-02 | |||
| ENSSSCG00000042682 | −6vs−14 |
| GO:0038127 | ERBB signaling pathway | 4.87E-03 |
| GO:0007173 | epidermal growth factor receptor signaling pathway | 3.85E-03 | |||
| ENSSSCG00000041987 | −6vs−14, −2vs−14, 1vs−14 |
| GO:0050688 | regulation of defense response to virus | 1.50E-02 |
|
| GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 4.03E-02 | ||
| ENSSSCG00000051701 | −2vs−14, 1vs−14 |
| ssc04530 | Tight junction | 1.75E-03 |
| XLOC_018030 | −2vs−14 |
| ssc04921 | Oxytocin signaling pathway | 6.73E-03 |
| ssc04923 | Regulation of lipolysis in adipocytes | 3.09E-02 | |||
| XLOC_025146 | −10vs−14, −6vs−14, −2vs−14, 1vs−14 |
| GO:0030879 | mammary gland development | 1.49E-06 |
| GO:0007595 | lactation | 1.48E-03 | |||
| ENSSSCG00000041015 | 1vs−14 |
| GO:0030879 | mammary gland development | 1.49E-06 |
| GO:0061180 | mammary gland epithelium development | 2.94E-03 | |||
| GO:0008144 | drug binding | 3.27E-02 | |||
| XLOC_005878 | −6vs−14, −2vs−14 |
| GO:0009792 | embryo development ending in birth or egg hatching | 4.80E-02 |
| XLOC_010589[ | −2vs−14, 1vs−14 |
| ssc04920 | Adipocytokine signaling pathway | 6.51E-03 |
| ENSSSCG00000046607 | −6vs−14, −2vs−14, 1vs−14 |
| ssc00512 | Mucin type O-glycan biosynthesis | 6.33E-04 |
|
| ssc04530 | Tight junction | 1.75E-03 | ||
| ssc04921 | Oxytocin signaling pathway | 6.73E-03 | |||
| ssc04920 | Adipocytokine signaling pathway | 6.51E-03 | |||
| ENSSSCG00000050015 | −6vs−14, −2vs−14, 1vs−14 |
| GO:0030879 | mammary gland development | 1.49E-06 |
| GO:0071396 | cellular response to lipid | 2.42E-02 | |||
| GO:0038127 | ERBB signaling pathway | 4.87E-03 | |||
| GO:0032526 | response to retinoic acid | 4.35E-03 | |||
| GO:0007173 | epidermal growth factor receptor signaling pathway | 3.85E-03 | |||
| ENSSSCG00000042000 | −2vs−14, 1vs−14 |
| GO:0050688 | regulation of defense response to virus | 1.50E-02 |
| XLOC_002435 | −2vs−14 |
| GO:0008144 | drug binding | 3.27E-02 |
| ENSSSCG00000049698 | −2vs−14 |
| ssc04530 | Tight junction | 1.75E-03 |
| ssc04921 | Oxytocin signaling pathway | 6.73E-03 | |||
| ssc04670 | Leukocyte transendothelial migration | 1.92E-02 | |||
| GO:0008144 | drug binding | 3.27E-02 | |||
| ENSSSCG00000048264 | 1vs−14 |
| ssc00512 | Mucin type O-glycan biosynthesis | 6.33E-04 |
| XLOC_003621 | 1vs−14 |
| GO:0008144 | drug binding | 3.27E-02 |
GO, gene ontology; KEGG, Kyoto encyclopedia of genes and genomes.
Indicates the lncRNAs and their target genes involved in the significant module by WGCNA.
Figure 6Network plot of the promising candidate lncRNAs, genes and pathways. The light blue, green and purple indicate lncRNAs, genes and pathways, respectively.